- Pulse Biosciences shares hit a new 52-week high of $46.03 during mid-day trading.
- The company reported an EPS of ($0.36) and revenue of $0.43 million for its latest quarter.
- Several institutional investors adjusted their stakes, with the stock maintaining a consensus rating of Moderate Buy.